According to Future Market Insights’ recent report, the spine pain market is forecast to register a CAGR of 5% from 2023 to 2033, reaching a valuation of US$ 12.47 Billion. Anti-inflammatory medications’ minor side effects are encouraging an increase in their usage as pain relievers. The effectiveness of pharmaceuticals like diclofenac, ibuprofen, and naproxen as …
Continue reading “Spine Pain Market is expected to garner a value of US$ 12.47 Billion by 2033”